Glucocorticoid excess induces long-lasting changes in body composition in male C57BI/6J mice only with high-fat diet

Physiological Reports

Volumn 1, Issue 5, 2013, Pages

  Auvinen, Hanna E ^a   Coomans, Claudia P ^a   Boon, Mariëtte R ^a   Romijn, Johannes A ^a,b   Biermasz, Nienke R ^a   Meijer, Onno C ^a   Havekes, Louis M ^a,c   Smit, Johannes W A ^a,d   Rensen, Patrick C N ^a   Pereira, Alberto M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c TNO   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Body composition; Corticosterone; Metabolic syndrome; Mice

Indexed keywords

CORTICOSTERONE; DRINKING WATER; FATTY ACID; GLUCOCORTICOID; INSULIN; LIPID; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIRCADIAN RHYTHM; CONTROLLED STUDY; CUSHING SYNDROME; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HYPERINSULINEMIC-EUGLYCEMIC CLAMP TECHNIQUE; LIPID DIET; LOW FAT DIET; MALE; MOUSE; NONHUMAN;

EID: 85009069424     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.1002/phy2.103     Document Type: Article

References (27)

1. Akana, S. F., C. S. Cascio, J. Shinsako, and M. F. Dallman. 1985. CORT: narrow range required for normal body and thymus weight and ACTH. Am. J. Physiol. 249: R527–R532.
2. Arnaldi, G., A. Angeli, A. B. Atkinson, X. Bertagna, F. Cavagnini, G. P. Chrousos, et al. 2003. Diagnosis and complications of Cushing’s syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 88: 5593–5602.
3. Balbo, M., R. Leproult, and E. Van Cauter. 2010. Impact of sleep and its disturbances on hypothalamo-pituitary-adrenal axis activity. Int. J Endocrinol. 2010: 759234.
4. Barahona, M. J., N. Sucunza, E. Resmini, J. M. Fernandez-Real, W. Ricart, J. M. Moreno-Navarrete, et al. 2009. Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing’s syndrome. J. Clin. Endocrinol. Metab. 94: 3365–3371.
5. Bell, M. E., S. Bhatnagar, J. Liang, L. Soriano, T. R. Nagy, and M. F. Dallman. 2000. Voluntary sucrose ingestion, like CORT replacement, prevents the metabolic deficits of adrenalectomy. J. Neuroendocrinol. 12: 461–470.
6. Bhatnagar, S., M. E. Bell, L. Soriano, T. R. Nagy, and M. F. Dallman. 2000. CORT facilitates saccharin intake in adrenalectomized rats. Does CORT increase stimulus salience? J. Neuroendocrinol. 12: 453–460.
7. Chandola, T., E. Brunner, and M. Marmot. 2006. Chronic stress at work and the metabolic syndrome: prospective study. BMJ 332: 521–525.
8. Christ-Crain, M., B. Kola, F. Lolli, C. Fekete, D. Seboek, G. Wittmann, et al. 2008. AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing’s syndrome. FASEB J. 22: 1672–1683.
9. Dallman, M. F., N. Pecoraro, S. F. Akana, S. E. La Fleur, F. Gomez, H. Houshyar, et al. 2003. Chronic stress and obesity: a new view of “comfort food”. Proc. Natl. Acad. Sci. USA 100: 11696–11701.
10. Dalm, S., V. Brinks, M. H. van der Mark, E. R. de Kloet, and M. S. Oitzl. 2008. Non-invasive stress-free application of glucocorticoid ligands in mice. J. Neurosci. Methods 170: 77–84.
11. Dekkers, O. M., N. R. Biermasz, A. M. Pereira, F. Roelfsema, M. O. van Aken, J. H. Voormolen, et al. 2007. Mortality in patients treated for Cushing’s disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma. J. Clin. Endocrinol. Metab. 92: 976–981.
12. Faggiano, A., R. Pivonello, S. Spiezia, M. C. De Martino, M. Filippella, C. Di Somma, et al. 2003. Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing’s disease during active disease and 1 year after disease remission. J. Clin. Endocrinol. Metab. 88: 2527–2533.
13. la Fleur, S. E., S. F. Akana, S. Manalo, and M. F. Dallman. 2004. Interaction between CORT and insulin in obesity: regulation of lard intake and fat stores. Endocrinology 145: 2174–2185.
14. Giordano, R., A. Picu, E. Marinazzo, V. D’Angelo, R. Berardelli, I. Karamouzis, et al. 2011. Metabolic and cardiovascular outcomes in patients with Cushing’s syndrome of different aetiologies during active disease and 1 year after remission. Clin. Endocrinol. (Oxf) 75: 354–360.
15. Gounarides, J. S., M. Korach-Andre, K. Killary, G. Argentieri, O. Turner, and D. Laurent. 2008. Effect of dexamethasone on glucose tolerance and fat metabolism in a diet-induced obesity mouse model. Endocrinology 149: 758–766.
16. Karatsoreos, I. N., S. M. Bhagat, N. P. Bowles, Z. M. Weil, D. W. Pfaff, and B. S. McEwen. 2010. Endocrine and physiological changes in response to chronic CORT: a potential model of the metabolic syndrome in mouse. Endocrinology 151: 2117–2127.
17. Lamberts, S. W., H. A. Bruining, and F. H. de Jong. 1997. Corticosteroid therapy in severe illness. N. Engl. J. Med. 337: 1285–1292.
18. Mather, K. 2009. Surrogate measures of insulin resistance: of rats, mice, and men. J. Clin. Endocrinol. Metab. 296: E398–E399.
19. Newell-Price, J., X. Bertagna, A. B. Grossman, and L. K. Nieman. 2006. Cushing’s syndrome. Lancet 367: 1605–1617.
20. Pecoraro, N., F. Reyes, F. Gomez, A. Bhargava, and M. F. Dallman. 2004. Chronic stress promotes palatable feeding, which reduces signs of stress: feedforward and feedback effects of chronic stress. Endocrinology 145: 3754–3762.
21. Pereira, A. M., M. O. van Aken, H. van Dulken, P. J. Schutte, N. R. Biermasz, J. W. Smit, et al. 2003. Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing’s disease. J. Clin. Endocrinol. Metab. 88: 5858–5864.
22. van Raalte, D. H., D. M. Ouwens, and M. Diamant. 2009. Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur. J. Clin. Invest. 39: 81–93.
23. Sahar, S., and P. Sassone-Corsi. 2012. Regulation of metabolism: the circadian clock dictates the time. Trends Endocrinol. Metab. 23: 1–8.
24. Strack, A. M., R. J. Sebastian, M. W. Schwartz, and M. F. Dallman. 1995. Glucocorticoids and insulin: reciprocal signals for energy balance. Am. J. Physiol. 268: R142–R149.
25. Voshol, P. J., M. C. Jong, V. E. Dahlmans, D. Kratky, S. Levak-Frank, R. Zechner, et al. 2001. In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake. Diabetes 50: 2585–2590.
26. Warne, J. P., S. F. Akana, A. B. Ginsberg, H. F. Horneman, N. C. Pecoraro, and M. F. Dallman. 2009. Disengaging insulin from CORT: roles of each on energy intake and disposition. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296: R1366–R1375.
27. Watson, M. L., L. M. Baehr, H. M. Reichardt, J. P. Tuckermann, S. C. Bodine, and J. D. A. Furlow. 2012. Cell autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure. Am. J. Physiol. Endocrinol. Metab. 302: E1210–E1220.